| Name: | Bendamustine Dimer 2-Allyl Ester |
| Catalogue No. | VE007308 |
| CAS No. | N/A |
| Molecular Formula | C35H45Cl3N6O4 |
| Molecular Weight | 720.13 g/mol |
| Status | In-Stock |
| IUPAC Name | 4-(5-((2-((4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate allyl ester |
| Description | Bendamustine Dimer 2-Allyl Ester ( CAS No: N/A ) or 4-(5-((2-((4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate allyl ester chemical group organic compound is associate impurity of Bendamustine. Bendamustine may be a therapy medication utilized in the treatment of chronic leukemia (CLL), myeloma, and non-Hodgkin's malignant neoplastic disease |
| References | “Sci-Hub | Determination and Characterization of Two Degradant Impurities in Bendamustine Hydrochloride Drug Product | 10.1093/Chromsci/Bmv070.” Hkvisa.net, 2015, sci-hub.hkvisa.net/10.1093/chromsci/bmv070. |
